These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Therapy of X-linked adrenoleukodystrophy. Semmler A; Köhler W; Jung HH; Weller M; Linnebank M Expert Rev Neurother; 2008 Sep; 8(9):1367-79. PubMed ID: 18759549 [TBL] [Abstract][Full Text] [Related]
9. Endocrine dysfunction in adrenoleukodystrophy. Engelen M; Kemp S; Eichler F Handb Clin Neurol; 2021; 182():257-267. PubMed ID: 34266597 [TBL] [Abstract][Full Text] [Related]
10. Reproductive function in men affected by X-linked adrenoleukodystrophy/adrenomyeloneuropathy. Stradomska TJ; Kubalska J; Janas R; Tylki-Szymanska A Eur J Endocrinol; 2012 Feb; 166(2):291-4. PubMed ID: 22048970 [TBL] [Abstract][Full Text] [Related]
11. X-linked adrenoleukodystrophy in women: a cross-sectional cohort study. Engelen M; Barbier M; Dijkstra IM; Schür R; de Bie RM; Verhamme C; Dijkgraaf MG; Aubourg PA; Wanders RJ; van Geel BM; de Visser M; Poll-The BT; Kemp S Brain; 2014 Mar; 137(Pt 3):693-706. PubMed ID: 24480483 [TBL] [Abstract][Full Text] [Related]
12. Lentiviral hematopoietic cell gene therapy for X-linked adrenoleukodystrophy. Cartier N; Hacein-Bey-Abina S; Bartholomae CC; Bougnères P; Schmidt M; Kalle CV; Fischer A; Cavazzana-Calvo M; Aubourg P Methods Enzymol; 2012; 507():187-98. PubMed ID: 22365775 [TBL] [Abstract][Full Text] [Related]
13. The Natural History of Adrenal Insufficiency in X-Linked Adrenoleukodystrophy: An International Collaboration. Huffnagel IC; Laheji FK; Aziz-Bose R; Tritos NA; Marino R; Linthorst GE; Kemp S; Engelen M; Eichler F J Clin Endocrinol Metab; 2019 Jan; 104(1):118-126. PubMed ID: 30252065 [TBL] [Abstract][Full Text] [Related]
14. Spinal cord atrophy as a measure of severity of myelopathy in adrenoleukodystrophy. van de Stadt SIW; van Ballegoij WJC; Labounek R; Huffnagel IC; Kemp S; Nestrasil I; Engelen M J Inherit Metab Dis; 2020 Jul; 43(4):852-860. PubMed ID: 32077106 [TBL] [Abstract][Full Text] [Related]
15. Clinical course and endocrine dysfunction in X-linked adrenoleukodystrophy: A case series. Matos T; Costa C; Araújo AN; do Vale S Endocrinol Diabetes Nutr (Engl Ed); 2023; 70(6):421-428. PubMed ID: 37356877 [TBL] [Abstract][Full Text] [Related]
16. Predominance of the adrenomyeloneuropathy phenotype of X-linked adrenoleukodystrophy in The Netherlands: a survey of 30 kindreds. van Geel BM; Assies J; Weverling GJ; Barth PG Neurology; 1994 Dec; 44(12):2343-6. PubMed ID: 7991123 [TBL] [Abstract][Full Text] [Related]
17. [Adrenal insufficiency as part of X-linked adrenoleukodystrophy]. Enikeeva SR; Chugunov IS; Kareva MA; Kurkina MV; Zakharova EY; Michailova SV; Bezlepkina OB; Peterkova VA; Mokrysheva NG Probl Endokrinol (Mosk); 2023 Dec; 70(3):83-92. PubMed ID: 39069776 [TBL] [Abstract][Full Text] [Related]
18. Potential Risks to Stable Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Children With Cerebral X-linked Adrenoleukodystrophy. Kühl JS; Kupper J; Baqué H; Ebell W; Gärtner J; Korenke C; Spors B; Steffen IG; Strauss G; Voigt S; Weschke B; Weddige A; Köhler W; Steinfeld R JAMA Netw Open; 2018 Jul; 1(3):e180769. PubMed ID: 30646031 [TBL] [Abstract][Full Text] [Related]
19. Retrospective evaluation of patients with X-linked adrenoleukodystrophy with a wide range of clinical presentations: a single center experience. Olgac A; Kasapkara ÇS; Derinkuyu B; Yüksel D; Çetinkaya S; Aksoy A; Ceylaner S; Güleray N; Yeşilipek A; Aydın Hİ; Orgun LT; Kılıç M J Pediatr Endocrinol Metab; 2021 Sep; 34(9):1169-1179. PubMed ID: 34162029 [TBL] [Abstract][Full Text] [Related]
20. Lovastatin therapy for X-linked adrenoleukodystrophy: clinical and biochemical observations on 12 patients. Pai GS; Khan M; Barbosa E; Key LL; Craver JR; Curé JK; Betros R; Singh I Mol Genet Metab; 2000 Apr; 69(4):312-22. PubMed ID: 10870849 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]